Summary
The European Parliament approves a decision to subject the new psychoactive substance MDMB-CHMICA to control measures to mitigate health risks. 10 03.03.2017
Other
health
criminal law
public safety
Key points
- The regulation targets a specific new psychoactive substance known as MDMB-CHMICA.
- Control measures will be implemented through a Council decision to manage health and safety risks across the EU.
- The process follows established EU legal frameworks for the risk assessment and control of new psychoactive substances.
- Parliamentary oversight ensures that any significant changes to the approved text must be communicated back to the European Parliament.
Documents (PDFs)
REPORT on the draft Council implementing decision on subjecting methyl 2-[[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA) to control measures
Subjecting the new psychoactive substance methyl 2-[[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA) to control measures *
These raw data are provided by the Open Data Portal of the European Union (data.europa.eu) and are licensed under ODC-BY 1.0.